Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +2.31% | +2.31% | -32.49% |
12/03 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
12/03 | North American Morning Briefing : Inflation Data -2- | DJ |
Business Summary
Number of employees: 43
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Cancer Therapies
100.0
%
| 16 | 100.0 % | 9 | 100.0 % | -41.35% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 9 | 100.0 % | -41.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Manfredi
FOU | Founder | 53 | 01/16/01 |
Jotin Marango
DFI | Director of Finance/CFO | 45 | 25/22/25 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | 29/02 |
Michelle Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
Rebecca Cohen
IRC | Investor Relations Contact | - | - |
Human Resources Officer | - | 01/21/01 | |
Jeffrey Ecsedy
PRN | Corporate Officer/Principal | 54 | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 01/16/01 | |
David Bonita
BRD | Director/Board Member | 48 | - |
Director/Board Member | 55 | 01/20/01 | |
Iain Dukes
BRD | Director/Board Member | 65 | 01/16/01 |
Owen Hughes
CHM | Chairman | 49 | 15/22/15 |
Richard Wooster
BRD | Director/Board Member | 59 | 21/22/21 |
Mark Manfredi
FOU | Founder | 53 | 01/16/01 |
Maria Koehler
BRD | Director/Board Member | 67 | 15/21/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,889,525 | 38,958,058 ( 93.00 %) | 0 | 93.00 % |
Stock B | 0 | 4,153,439 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.49% | 62.74M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- IKNA Stock
- Company Ikena Oncology, Inc.